Skip Nav Destination
Close Modal
1-20 of 427
Search Results for prescription drug prices
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Journal Article
J Health Polit Policy Law (2022) 47 (4): 523–526.
Published: 01 August 2022
...Joseph White [email protected] Feldman, Robin . Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices . New York : Cambridge University Press , 2019 . 186 pp. $29.95 cloth. Copyright © 2022 by Duke University Press 2022...
View articletitled, <span class="search-highlight">Drugs</span>, Money, and Secret Handshakes: The Unstoppable Growth of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> <span class="search-highlight">Prices</span>
View
PDF
for article titled, <span class="search-highlight">Drugs</span>, Money, and Secret Handshakes: The Unstoppable Growth of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> <span class="search-highlight">Prices</span>
Journal Article
J Health Polit Policy Law (2021) 46 (6): 1053–1068.
Published: 01 December 2021
...Rachel E. Sachs Abstract Throughout his four years in office, President Trump made prescription drug pricing a focus of his policy agenda. President Trump not only used strong language to criticize the pharmaceutical industry and its practices but also introduced ambitious reform policies that had...
View articletitled, The Rhetorical Transformations and Policy Failures of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> <span class="search-highlight">Pricing</span> Reform under the Trump Administration
View
PDF
for article titled, The Rhetorical Transformations and Policy Failures of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> <span class="search-highlight">Pricing</span> Reform under the Trump Administration
Journal Article
J Health Polit Policy Law (2022) 47 (6): 621–628.
Published: 01 December 2022
... for a century, rising prices have forced many people with diabetes in the United States to ration that essential medication (Fralick and Kesselheim 2019 ). Medicare enrollees often do not fill prescriptions for cancer and other specialty drugs because of the costs they face as a result of high prices...
View articletitled, The <span class="search-highlight">Price</span> of Progress: Managing <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Spending
View
PDF
for article titled, The <span class="search-highlight">Price</span> of Progress: Managing <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Spending
Journal Article
J Health Polit Policy Law (2021) 46 (4): 599–609.
Published: 01 August 2021
... coverage. These policies could provide important financial protections for Americans against high prescription drug prices. Despite widespread public support for addressing prescription drug prices, many of Biden's plans rely on congressional action, which will be complicated by the narrow majority held...
View articletitled, <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Priorities under the Biden Administration
View
PDF
for article titled, <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Priorities under the Biden Administration
Journal Article
J Health Polit Policy Law (2008) 33 (6): 1079–1106.
Published: 01 December 2008
.... Such a partnership could incorporate key elements of both programs: capacity to accept large numbers of enrollees (like Medicare) and leverage to negotiate prescription drug prices (like the VA). Moreover, it could be implemented at no cost to the VA while achieving savings for Medicare and beneficiaries. Duke...
View articletitled, Controlling <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Costs: Regulation and the Role of Interest Groups in Medicare and the Veterans Health Administration
View
PDF
for article titled, Controlling <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span> Costs: Regulation and the Role of Interest Groups in Medicare and the Veterans Health Administration
Journal Article
J Health Polit Policy Law (2022) 47 (6): 779–796.
Published: 01 December 2022
... on market prices. The authors review the application of IRP to cap the prices of negotiated outcomes in the context of US proposals for changing the way prescription drug prices are established for the Medicare program. They examine the economic, political, and administrative issues associated with the use...
View articletitled, International Reference <span class="search-highlight">Pricing</span> in the Context of US <span class="search-highlight">Drug</span> Policy
View
PDF
for article titled, International Reference <span class="search-highlight">Pricing</span> in the Context of US <span class="search-highlight">Drug</span> Policy
Journal Article
J Health Polit Policy Law (2011) 36 (2): 295–316.
Published: 01 April 2011
... to Parallel Trade . National Bureau of Economic Research Working Paper No. 12968 . Cambridge, MA : NBER . Kyle M. Allsbrook J. S. Schulman K. A. . 2008 . Does Reimportation Reduce Price Differences for Prescription Drugs? Lessons from the European Union . Health Services Research 43...
View articletitled, Commercial Importation of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drugs</span> in the United States: Short-Run Implications
View
PDF
for article titled, Commercial Importation of <span class="search-highlight">Prescription</span> <span class="search-highlight">Drugs</span> in the United States: Short-Run Implications
Journal Article
J Health Polit Policy Law (2003) 28 (1): 109–132.
Published: 01 February 2003
..., Rebate, Price Control and Bulk Purchasing Legislation . Denver, CO: National Conference of State Legislatures. Cauchi, Richard, and Karmen Hanson. 2002 . 2002 Prescription Drug Discount, Bulk Purchasing, and Price-Related Legislation . Denver, CO: National Conference of State Legislatures. Conlan...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 853–877.
Published: 01 December 2022
... enacted the MMA, creating Medicare Part D—a government-subsidized but privately administered prescription drug coverage program, in which private plan sponsors set premiums, negotiate prices with manufacturers, establish formularies, and use common management tools to control costs, subject to minimum...
FIGURES
| View All (8)
View articletitled, Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, <span class="search-highlight">Drug</span> Manufacturers, and the Federal Government
View
PDF
for article titled, Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, <span class="search-highlight">Drug</span> Manufacturers, and the Federal Government
Journal Article
J Health Polit Policy Law (2022) 47 (6): 731–753.
Published: 01 December 2022
..., 2019. That September the House Ways and Means Committee ( 2019 ) issued a devastating comparison of US and international prescription drug prices, with insulin as one of the major categories. President Trump, who had made lowering drug prices “a focus of his policy agenda . . . used strong language...
FIGURES
Journal Article
J Health Polit Policy Law (2003) 28 (2-3): 473–508.
Published: 01 June 2003
... . New York:Commonwealth Fund. Allen, Thomas H. 1998 . Prescription Drug Pricing in the First Congressional District in Maine: An International Price Comparison . Minority Staff Report, Committee on Government Reform and Oversight, U.S. House of Representatives, Washington, DC. Alpha Center...
Journal Article
J Health Polit Policy Law (2007) 32 (2): 187–219.
Published: 01 April 2007
... of American Democracy . New Haven, CT: Yale University Press. Hahn, Jim. 2005 . The Pros and Cons of Allowing the Federal Government to Negotiate Prescription Drug Prices . Congressional Research Service (CRS) Report for Congress RS22059, February 18 . Washington, DC: CRS. Heaney, Michael T. 2006...
View articletitled, Through the Looking Glass: The Politics of the Medicare <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span>, Improvement, and Modernization Act
View
PDF
for article titled, Through the Looking Glass: The Politics of the Medicare <span class="search-highlight">Prescription</span> <span class="search-highlight">Drug</span>, Improvement, and Modernization Act
Journal Article
J Health Polit Policy Law (2022) 47 (6): 879–895.
Published: 01 December 2022
... the Bayh-Dole Act as ushering in a new era of technological advances, others have been less sanguine about its impact. In recent years, the high price of prescription drugs and the patenting of COVID-19 therapeutics and vaccines developed with substantial federal government support have rekindled...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 755–778.
Published: 01 December 2022
...-rebate-program . Dolan Rachel , and Tian Marian . 2020 . “ Pricing and Payment for Medicaid Prescription Drugs .” Kaiser Family Foundation, January 23 . https://www.kff.org/medicaid/issue-brief/pricing-and-payment-for-medicaid-prescription-drugs/ . Feldstein Paul J. 2006...
FIGURES
View articletitled, Assessing US Pharmaceutical Policy and <span class="search-highlight">Pricing</span> Reform Legislation in Light of European <span class="search-highlight">Price</span> and Cost Control Strategies
View
PDF
for article titled, Assessing US Pharmaceutical Policy and <span class="search-highlight">Pricing</span> Reform Legislation in Light of European <span class="search-highlight">Price</span> and Cost Control Strategies
Journal Article
J Health Polit Policy Law (2022) 47 (5): 583–607.
Published: 01 October 2022
... (Gill 2020 ) and that prices for prescription drugs can vary significantly across states and zip codes because of differences in pharmacies, payors, and other factors (Kullgren et al. 2017 ), formulary placement can further impede interchangeability of drug products. This method of generating...
Journal Article
J Health Polit Policy Law (2011) 36 (3): 555–563.
Published: 01 June 2011
... , September 19 . www.prospect.org/cs/articles?article=good_medicine . Hilzenrath D. S. 2010 . Medicare “Doughnut Hole” Relief Could Be Offset by Higher Prescription Drug Prices . Washington Post , September 21 . www.washingtonpost.com/wpdyn/content/article/2010/09/20/AR2010092005790.html...
Journal Article
J Health Polit Policy Law (2003) 28 (1): 9–40.
Published: 01 February 2003
..., February 2003. Copyright © 2003 by
Duke University Press.
10 Journal of Health Politics, Policy and Law
the majority of states to reduce the reimbursement of the ingredient cost
component of a prescription drug’s price. Historically, these reimburse-
ment rates had been based on the average...
Journal Article
J Health Polit Policy Law (2023) 48 (2): 215–239.
Published: 01 April 2023
... . Brennan Hannah , Kapczynski Amy , Monahan Christine H. , and Rizvi Zain . 2016 . “ A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health .” Yale Journal of Law and Technology 18 , no. 1 : 275 – 354 . https://yjolt.org/sites/default/files...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 673–690.
Published: 01 December 2022
... Administration accelerated approval drug pricing The impact of drug coverage and pricing policies on state Medicaid programs and state budgets is an understudied area within prescription drug pricing debates. Unlike the federal government, nearly all states have a balanced budget requirement, though...
FIGURES
View articletitled, Medicaid and Accelerated Approval: Spending on <span class="search-highlight">Drugs</span> with and without Proven Clinical Benefits
View
PDF
for article titled, Medicaid and Accelerated Approval: Spending on <span class="search-highlight">Drugs</span> with and without Proven Clinical Benefits
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (2005) 30 (3): 327–366.
Published: 01 June 2005
.... Eisenberg, J. M. 1998 . Health Services Research in a Market Oriented Health Care System. Health Affairs 17 : 98 -108. Families USA. 2003 . Out-of-Bounds: Rising Prescription Drug Prices for Seniors . www.familiesusa.org/site/DocServer/Out_of_Bounds.pdf?docID=1522 . Feldstein, P. 1993 . Health...
1
